Tuesday, May 28, 2024

HomeStock MarketAC Immune rockets 47% on Alzheimer's therapy deal with Takeda (NASDAQ:ACIU)

AC Immune rockets 47% on Alzheimer’s therapy deal with Takeda (NASDAQ:ACIU)

Alzheimers Concept Horizontal

travellinglight/iStock via Getty Images

Shares of AC Immune (NASDAQ:ACIU) shot up 47% on Monday after the Swiss drug developer announced an option and licensing deal potentially worth over $2B with Japanese drugmaker Takeda (TAK) for its Alzheimer’s drug candidate ACI-24.060.

Under the deal, AC Immune

Source link

Bookmark (0)
ClosePlease login
- Advertisment -spot_img

Most Popular

Sponsored Business

- Advertisment -spot_img